Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Wood Panel Products01:18

Wood Panel Products

418
Wood panel products are essential materials used in construction for applications such as flooring, siding, and roofing, typically available in standard dimensions of 4 feet by 8 feet, with thicknesses varying from one-quarter of an inch to one and one-eighth inches. Among the most common types of wood panels is plywood, which is produced by gluing multiple layers of thin wood veneers under pressure. The grain of the outer veneers runs lengthwise, while the grains of the interior layers run...
418
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

430
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
430
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

14.6K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.6K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

25.0K
Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
25.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers.

Journal of experimental & clinical cancer research : CR·2026
Same author

Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.

Lancet (London, England)·2026
Same author

Chemotherapy-Induced Oral Mucosal Injury Is Defined by p53 Activation, Cell Cycle Arrest and Diverse Epithelial Progenitor Dynamics.

bioRxiv : the preprint server for biology·2026
Same author

Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.

JCO precision oncology·2026
Same author

CLO26-074: A Phase I Study of Safety and Immunogenicity of Survivin Long Peptide Vaccine (SurVaxM) in Patients with Metastatic Neuroendocrine Tumors (NETs).

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

CLO26-074: A Phase I Study of Safety and Immunogenicity of Survivin Long Peptide Vaccine (SurVaxM) in Patients with Metastatic Neuroendocrine Tumors (NETs).

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Related Experiment Video

Updated: Feb 15, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.0K

Multi-gene Panel Testing in Breast Cancer Management.

Christos Fountzilas1, Virginia G Kaklamani2

  • 1Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, 7979 Wurzbach Road, San Antonio, TX, 78229, USA.

Cancer Treatment and Research
|January 20, 2018
PubMed
Summary

Hereditary breast cancer, often linked to BRCA1/BRCA2 mutations, can now be analyzed using multi-gene panel testing. This guide helps interpret results for better clinical decisions in cancer genetics.

Keywords:
BRCA1/2Deleterious mutationsGene panel testingHereditary breast cancer syndromePenetrancePrevention

More Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

13.1K
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
08:11

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis

Published on: August 14, 2016

32.6K

Related Experiment Videos

Last Updated: Feb 15, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.0K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

13.1K
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
08:11

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis

Published on: August 14, 2016

32.6K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Hereditary breast cancer accounts for ~10% of cases, primarily due to BRCA1 and BRCA2 mutations.
  • These genes are crucial for DNA repair via homologous recombination.
  • Advances in next-generation sequencing enable cost-effective, simultaneous analysis of multiple genes.

Purpose of the Study:

  • To provide a guide for interpreting multi-gene panel testing results in breast cancer.
  • To assist in clinical decision-making based on genetic testing information.
  • To address the growing use of panel testing in hereditary cancer assessment.

Main Methods:

  • Review of current literature on hereditary breast cancer genetics.
  • Analysis of data from large-scale cancer genetic testing studies.
  • Focus on interpretation of germline mutations in high- and moderate-penetrance genes.

Main Results:

  • Multi-gene panel testing offers a comprehensive approach to identifying hereditary cancer predispositions.
  • Understanding the clinical validity and utility of these panels is evolving with new data.
  • Interpretation requires consideration of gene penetrance and associated risks.

Conclusions:

  • Multi-gene panel testing is a valuable tool for assessing hereditary breast cancer risk.
  • Accurate interpretation of panel results is essential for guiding patient management and clinical decisions.
  • Continued research is needed to fully characterize moderate-penetrance genes in cancer genetics.